(Circulation. 1995;92:2066-2071.)
© 1995 American Heart Association, Inc.
Articles |
Angiotensin-Converting Enzyme and Apolipoprotein E Genotypes and Restenosis After Coronary Angioplasty
From the Department of Biochemistry (F.M. van B., C.D.S.M.), Department of Cardiology (F.A.G., R.R.T.), and University Department of Medicine (R.R.T., V.B.), Royal Perth (Australia) Hospital.
Correspondence to Frank M. van Bockxmeer, PhD, Department of Biochemistry, Royal Perth Hospital, Wellington Street, Perth, Western Australia 6000.
Background An insertion/deletion (I/D) polymorphism in the gene for angiotensin-converting enzyme (ACE) has been associated with myocardial infarction and other cardiac pathology. There is evidence for a role of the renin-angiotensin system in cell growth and in the repair of damaged arterial walls, so the ACE gene was postulated to be a candidate gene affecting the important clinical problem of restenosis after percutaneous transluminal balloon coronary angioplasty (PTCA). Because restenosis is influenced by the apolipoprotein E (apoE) genotype, the possibility of a relation between ACE and apoE genotypes and restenosis was also sought.
Methods and Results Subjects (<70 years of age) were
prospectively followed and had coronary angiography 6 months
after PTCA to determine the presence or absence of
restenosis. Those who had angiography earlier and did not
have restenosis (
50% loss of gain at PTCA plus 50%
luminal diameter stenosis) also had angiography at 6 months.
The whole group (n=207) had a higher DD genotype
frequency than did 136 population control subjects (38% versus 26%,
P<.02); in PTCA patients, the frequency was the same in
those with and without prior myocardial infarction. The distribution of
ACE genotypes was not different in the 88 patients with and 119
patients without restenosis, while the 
4/4
genotype was more frequent in those with restenosis
(8 of 88 versus 3 of 118, P<.05). There was no effect of
the ACE genotype in noncarriers of the 4 allele, but
there was a significant effect in 4 carriers (P<.005).
The combined D and 4 carrier state showed a 16-fold
increase in the odds ratio for restenosis
(P<.02). Multiple linear regression examining the loss of
lumen as a continuous variable showed significant independent
effects of the ACE and apoE genotypes.
Conclusions Overall, the ACE genotype had no clear
influence on restenosis, but there was an interaction
between ACE and apoE genotypes. The combined carrier state for
the D and apoE 4 alleles substantially increased
restenosis. For loss of lumen as a continuous variable,
there were significant effects of both ACE and apoE genotypes.
While the observations may not affect current management, they no doubt
have implications in pathophysiology.
Key Words: genes • restenosis • apolipoproteins • angiotensin
This article has been cited by other articles:
 |
|
 |
|
  E. Milne, F. M. van Bockxmeer, L. Robertson, J. M. Brisbane, L. J. Ashton, R. J. Scott, and B. K. Armstrong Buccal DNA collection: comparison of buccal swabs with FTA cards. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 816 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Singh, B. J. Gersh, R. L. McClelland, K. K.L. Ho, J. T. Willerson, W. F. Penny, and D. R. Holmes Jr Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial J. Am. Coll. Cardiol., January 18, 2005; 45(2): 198 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Koch, J. Mehilli, A. Pfeufer, A. Schomig, and A. Kastrati Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting J. Lipid Res., December 1, 2004; 45(12): 2221 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hara, T. Matsushima, H. Satoh, N. Iso-o, H. Noto, M. Togo, S. Kimura, Y. Hashimoto, and K. Tsukamoto Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kolovou, D. Daskalova, and D. P. Mikhailidis Apolipoprotein E Polymorphism and Atherosclerosis Angiology, January 1, 2003; 54(1): 59 - 71. [Abstract] [PDF]
|
|
|
|
|
|
D. E. Cutlip, M. S. Chauhan, D. S. Baim, K. K. L. Ho, J. J. Popma, J. P. Carrozza, D. J. Cohen, and R. E. Kuntz Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2082 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bonnici, B. Keavney, R. Collins, and J. Danesh Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies BMJ, September 7, 2002; 325(7363): 517 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF]
|
|
|
|
 |
|
 T. Isbir, B. Agachan, H. Yilmaz, M. Aydin, I. Kara, D. Eker, and E. Eker Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease American Journal of Alzheimer's Disease and Other Dementias, July 1, 2001; 16(4): 205 - 210. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Kosokabe, K. Okumura, T. Sone, J. Kondo, H. Tsuboi, H. Mukawa, T. Tomida, T. Suzuki, H. Kamiya, H. Matsui, et al. Relation of a Common Methylenetetrahydrofolate Reductase Mutation and Plasma Homocysteine With Intimal Hyperplasia After Coronary Stenting Circulation, April 24, 2001; 103(16): 2048 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Newman, D. T. Laskowitz, W. D. White, J. L. Kirchner, H. P. Grocott, M. Stafford-Smith, M. H. Sketch, R. H. Jones, J. G. Reves, and A. M. Saunders Apolipoprotein E Polymorphisms and Age at First Coronary Artery Bypass Graft Anesth. Analg., April 1, 2001; 92(4): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Y. L. Zee, A. Fernandez-Ortiz, C. Macaya, E. Pintor, K. Lindpaintner, and A. Fernandez-Cruz ACE D/I Polymorphism and Incidence of Post-PTCA Restenosis : A Prospective, Angiography-Based Evaluation Hypertension, March 1, 2001; 37(3): 851 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhu, D. G. Kuhel, D. P. Witte, and D. Y. Hui Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in Mice Am. J. Pathol., December 1, 2000; 157(6): 1839 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I. C. Klausen, P. S. Hansen, Y. A. Kesaniemi, and O. Fargeman The Apolipoprotein {epsilon}4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction : A Substudy of the Scandinavian Simvastatin Survival Study Circulation, March 28, 2000; 101(12): 1366 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al. Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty Angiology, October 1, 1999; 50(10): 811 - 822. [Abstract] [PDF]
|
|
|
|
 |
|
 R. R. Taylor, C. D. S. Mamotte, K. Fallon, and F. M. van Bockxmeer Elite athletes and the gene for angiotensin-converting enzyme J Appl Physiol, September 1, 1999; 87(3): 1035 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kastrati, A. Schomig, S. Elezi, H. Schuhlen, M. Wilhelm, and J. Dirschinger Interlesion Dependence of the Risk for Restenosis in Patients With Coronary Stent Placement in Multiple Lesions Circulation, June 23, 1998; 97(24): 2396 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ribichini, G. Steffenino, A. Dellavalle, G. Matullo, E. Colajanni, T. Camilla, A. Vado, G. Benetton, E. Uslenghi, and A. Piazza Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme : A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis Circulation, January 20, 1998; 97(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ferrucci, J. M. Guralnik, M. Pahor, T. Harris, M.-C. Corti, M.-C. MHS, B. T. Hyman, R. B. Wallace, and R. J. Havlik Apolipoprotein E {epsilon}2 Allele and Risk of Stroke in the Older Population Stroke, December 1, 1997; 28(12): 2410 - 2416. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. van Bockxmeer, C. D.S. Mamotte, S. D. Vasikaran, and R. R. Taylor Methylenetetrahydrofolate Reductase Gene and Coronary Artery Disease Circulation, January 7, 1997; 95(1): 21 - 23. [Abstract] [Full Text]
|
|